Therefore, we also observed the detection efficacy in EGFR and main types of mutations which are very important in the tumor response to chemotherapies, targeted and immune therapies, and acquirement of resistance, by tissue- and plasma-NGS. This evidence concerns the gene EGFR and neoplasm.